Literature DB >> 19438599

Characterization of regulatory T cells identified as CD4(+)CD25(high)CD39(+) in patients with active tuberculosis.

T Chiacchio1, R Casetti, O Butera, V Vanini, S Carrara, E Girardi, D Di Mitri, L Battistini, F Martini, G Borsellino, D Goletti.   

Abstract

Forkhead box P3 (FoxP3) is a transcription factor whose expression characterizes regulatory T cells (T(reg)), but it is also present on activated T cells, thus hindering correct T(reg) identification. Using classical markers for T(reg) recognition, discordant results were found in terms of T(reg) expansion during active tuberculosis (TB) disease. Recently CD39 has been shown to be an accurate marker for T(reg) detection. The objectives of this study were: (i) to identify T(reg) expressing CD39 in patients with TB and to compare the results with those obtained by the standard phenotypic markers; (ii) to evaluate if T(reg) are expanded in vitro by exogenous interleukin (IL)-2 or by antigen-specific stimulation; and (iii) to characterize T(reg) function on the modulation of antigen-specific responses. We enrolled 13 patients with pulmonary TB and 12 healthy controls. T(reg) were evaluated by flow cytometry ex vivo and after antigen-specific in vitro stimulation using CD25, FoxP3, CD127 and CD39 markers. Results indicate that CD39(+) cells within the CD4(+)CD25(high) cells have T(reg) properties (absence of interferon-gamma production and transforming growth factor-beta1 release upon stimulation). Ex vivo analysis did not show significant differences between TB patients and controls of T(reg) by classical or novel markers. In contrast, a significantly higher percentage of T(reg) was found in TB patients after antigen-specific stimulation both in the presence or absence of IL-2. Depletion of CD39(+) T(reg) increased RD1-specific responses significantly. In conclusion, CD39 is an appropriate marker for T(reg) identification in TB. These results can be useful for future studies to monitor Mycobacterium tuberculosis-specific response during TB.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19438599      PMCID: PMC2691975          DOI: 10.1111/j.1365-2249.2009.03908.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  19 in total

Review 1.  Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2000-04       Impact factor: 21.405

Review 2.  Natural regulatory T cells in infectious disease.

Authors:  Yasmine Belkaid; Barry T Rouse
Journal:  Nat Immunol       Date:  2005-04       Impact factor: 25.606

Review 3.  Regulatory T cells: friend or foe in immunity to infection?

Authors:  Kingston H G Mills
Journal:  Nat Rev Immunol       Date:  2004-11       Impact factor: 53.106

4.  Global epidemiology of tuberculosis.

Authors:  Christopher Dye
Journal:  Lancet       Date:  2006-03-18       Impact factor: 79.321

5.  Altered expression of lymphocyte differentiation antigens on phorbol ester-activated CD4+8+ T cells.

Authors:  E R Richie; B McEntire; J Phillips; J P Allison
Journal:  J Immunol       Date:  1988-06-15       Impact factor: 5.422

6.  CD4(+)CD25(+)FoxP3(+) regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease.

Authors:  Xinchun Chen; Boping Zhou; Meizhong Li; Qunyi Deng; Xueqiong Wu; Xiaohua Le; Chi Wu; Nicolas Larmonier; Wei Zhang; Hongmei Zhang; Huosheng Wang; Emmanuel Katsanis
Journal:  Clin Immunol       Date:  2007-01-17       Impact factor: 3.969

7.  Identification of a human CD8+ regulatory T cell subset that mediates suppression through the chemokine CC chemokine ligand 4.

Authors:  Simone A Joosten; Krista E van Meijgaarden; Nigel D L Savage; Tjitske de Boer; Frédéric Triebel; Annemieke van der Wal; Emile de Heer; Michèl R Klein; Annemieke Geluk; Tom H M Ottenhoff
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-02       Impact factor: 11.205

8.  In vitro expansion of CD4+CD25highFOXP3+CD127low/- regulatory T cells from peripheral blood lymphocytes of healthy Mycobacterium tuberculosis-infected humans.

Authors:  Jean-Michel Hougardy; Virginie Verscheure; Camille Locht; Françoise Mascart
Journal:  Microbes Infect       Date:  2007-06-30       Impact factor: 2.700

9.  Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression.

Authors:  Giovanna Borsellino; Markus Kleinewietfeld; Diletta Di Mitri; Alexander Sternjak; Adamo Diamantini; Raffaella Giometto; Sabine Höpner; Diego Centonze; Giorgio Bernardi; Maria Luisa Dell'Acqua; Paolo Maria Rossini; Luca Battistini; Olaf Rötzschke; Kirsten Falk
Journal:  Blood       Date:  2007-04-20       Impact factor: 22.113

10.  Regulatory T cells depress immune responses to protective antigens in active tuberculosis.

Authors:  Jean-Michel Hougardy; Sammy Place; Marc Hildebrand; Annie Drowart; Anne-Sophie Debrie; Camille Locht; Francoise Mascart
Journal:  Am J Respir Crit Care Med       Date:  2007-05-31       Impact factor: 21.405

View more
  31 in total

1.  Separation of human CD4+CD39+ T cells by magnetic beads reveals two phenotypically and functionally different subsets.

Authors:  Patrick J Schuler; Malgorzata Harasymczuk; Bastian Schilling; Stephan Lang; Theresa L Whiteside
Journal:  J Immunol Methods       Date:  2011-04-13       Impact factor: 2.303

Review 2.  T regulatory cells: Achilles' heel of Mycobacterium tuberculosis infection?

Authors:  Om Parkash; Sonali Agrawal; M Madhan Kumar
Journal:  Immunol Res       Date:  2015-07       Impact factor: 2.829

3.  Investigating the induction of vaccine-induced Th17 and regulatory T cells in healthy, Mycobacterium bovis BCG-immunized adults vaccinated with a new tuberculosis vaccine, MVA85A.

Authors:  Simone C de Cassan; Ansar A Pathan; Clare R Sander; Angela Minassian; Rosalind Rowland; Adrian V S Hill; Helen McShane; Helen A Fletcher
Journal:  Clin Vaccine Immunol       Date:  2010-05-19

4.  Mycobacterium bovis BCG Vaccination Induces Divergent Proinflammatory or Regulatory T Cell Responses in Adults.

Authors:  Mardi C Boer; Corine Prins; Krista E van Meijgaarden; Jaap T van Dissel; Tom H M Ottenhoff; Simone A Joosten
Journal:  Clin Vaccine Immunol       Date:  2015-05-06

5.  CD4(+) regulatory T cells in a cynomolgus macaque model of Mycobacterium tuberculosis infection.

Authors:  Angela M Green; Joshua T Mattila; Carolyn L Bigbee; Kale S Bongers; P Ling Lin; Joanne L Flynn
Journal:  J Infect Dis       Date:  2010-08-15       Impact factor: 5.226

6.  Ex-vivo characterization of regulatory T cells in pulmonary tuberculosis patients, latently infected persons, and healthy endemic controls.

Authors:  Martha Zewdie; Rawleigh Howe; Søren T Hoff; T Mark Doherty; Nahom Getachew; Azeb Tarekegne; Bamlak Tessema; Lawrence Yamuah; Abraham Aseffa; Markos Abebe
Journal:  Tuberculosis (Edinb)       Date:  2016-07-09       Impact factor: 3.131

7.  T regulatory cells and Th1/Th2 cytokines in peripheral blood from tuberculosis patients.

Authors:  X-Y He; L Xiao; H-B Chen; J Hao; J Li; Y-J Wang; K He; Y Gao; B-Y Shi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-03-21       Impact factor: 3.267

Review 8.  The immunology of tuberculosis: from bench to bedside.

Authors:  Keertan Dheda; Stephan K Schwander; Bingdong Zhu; Richard N van Zyl-Smit; Ying Zhang
Journal:  Respirology       Date:  2010-04       Impact factor: 6.424

Review 9.  The aging immune system and its relationship to the development of chronic obstructive pulmonary disease.

Authors:  Gulshan Sharma; Nicola A Hanania; Y Michael Shim
Journal:  Proc Am Thorac Soc       Date:  2009-12-01

10.  Different immunosuppressive mechanisms in multi-drug-resistant tuberculosis and non-tuberculous mycobacteria patients.

Authors:  R O Pinheiro; E B de Oliveira; G Dos Santos; G M Sperandio da Silva; B J de Andrade Silva; R M B Teles; A Milagres; E N Sarno; M P Dalcolmo; E P Sampaio
Journal:  Clin Exp Immunol       Date:  2013-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.